The goal of the Bioninnovations in Brain Cancer (BIBC) initiative is to establish itself as a global leader in the research, development, and application of advanced technologies for the treatment and detection of brain cancer. The program aims to achieve this by fostering collaboration between experts in cutting-edge technologies, cancer specialists and clinicians, with the ultimate goal of bringing new and innovative solutions to patients suffering from brain cancer.
Glioblastoma multiforme (GBM) is a devastating disease that likely will not be addressed without a larger concerted effort. Multi-unit partnership and collaboration is at the heart of the BIBC initiative to create breakthroughs in this recalcitrant disease.
R C Schneider Collegiate Professor
Professor of Neurosurgery
Professor of Cell and Developmental Biology
Co-Director, Brain Tumor Research and Translational Neuro-Oncology Laboratories
Professor of Neurosurgery
Professor of Cell and Developmental Biology
Co-Director, Brain Tumor Research and Translational Neuro-Oncology Laboratories
